ACCURAY INC (ARAY)

Accuray Showcases Advances in Radiation Therapy Solutions Designed to Improve the Cancer Treatment Experience at ESTRO 2024

/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company is showcasing advances in hardware and software designed to improve the...

Accuray Expands Global Training Center Network With Opening of New Facility in Genolier, Switzerland

/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that as part of its commitment to advancing patient care the company has opened a new...

Accuray to Report Third Quarter Fiscal 2024 Financial Results on May 1, 2024

/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2024, ended March 31, 2024, during a...

New Data from Two Clinical Studies Indicate High-Risk and Recurrent Prostate Cancers Can be Effectively Treated in 5 Days Using the Accuray CyberKnife® System

/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that new data presented at the 2024 Radiosurgery Society Meeting in Chicago, Illinois...

Notable Thursday Option Activity: AA, ARAY, ABR

Accuray Incorporated to Speak at Oppenheimer 34th Annual Healthcare MedTech & Services Conference

/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference...

Commit To Buy Accuray At $2, Earn 8.7% Annualized Using Options

7 Screaming Stock Buys for Under $5

While these under $5 stocks may be low priced, there’s nothing fundamentally cheap about these compelling enterprises.

Roth MKM starts Accuray at buy, cites expansion into emerging markets (NASDAQ:ARAY)

Roth MKM initiated coverage of Accuray (ARAY) with a buy rating, citing the company’s expansion into emerging markets such as China and India. Read more here.

Quebec Cancer Center is First in Canada to Treat Cancer Patients Using the Accuray Radixact® System

/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the team at Quebec's Montérégie Integrated Cancer Center, part of Charles-LeMoyne...

Accuray to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools...

Accuray GAAP EPS of -$0.10 misses by $0.05, revenue of $107.2M beats by $0.53M (NASDAQ:ARAY)

Accuray reports fiscal Q2 2024 financial results: GAAP EPS misses by $0.05, revenue beats by $0.53M. Reaffirms guidance for FY2024.

Accuray Reports Fiscal 2024 Second Quarter Financial Results

/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the second quarter and six-months ended December 31, 2023. Second...

Providence Swedish Radiosurgery Center in Seattle Invests in Second Accuray CyberKnife® System, a Robotic Delivery Device That Makes Extremely Precise Radiation Treatments Possible in 1-5 Sessions

/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Providence Swedish Radiosurgery Center in Seattle, Washington is enhancing its...

Accuray to Report Second Quarter Fiscal 2024 Financial Results on January 31, 2024

/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the second quarter of fiscal year 2024, ended December 31, 2023, during a...

Accuray Initiates Sales of the VitalHold™ Solution in Japan, Supporting Surface-guided Radiation Therapy on the Radixact® System

/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company has initiated sales of the VitalHold™* package supporting surface-guided...

Accuray Reports Fiscal 2024 First Quarter Financial Results

/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the first quarter of fiscal 2024 ended September 30, 2023. First...

Accuray to Participate in the 14th Annual Jefferies London Healthcare Conference

/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the 14th Annual Jefferies London Healthcare Conference. The management...

Accuray to Report First Quarter Fiscal 2024 Financial Results on November 7, 2023

/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2024, ended September 30, 2023, during a...

Accuray cuts 5% staff in cost-saving plan (NASDAQ:ARAY)

Accuray Incorporated (ARAY), a radiation therapy systems developer, is set to cut 6% of its workforce as part of a cost-saving initiative. Read more here.

Accuray Announces Approval of the Tomo® C Radiation Treatment Delivery System by China's National Medical Products Administration

/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the registration dossier for the CNNC-Accuray joint venture Tomo® C radiation therapy...

Accuray and Limbus AI Unveil Online Adaptive Therapy Solution for the Radixact® System at American Society for Radiation Oncology (ASTRO) Annual Meeting

/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company has a 510(k) pending for an online adaptive therapy option*, Cenos™, for...

Accuray Opens New Global Training Center at Madison, WI Headquarters to Advance Radiotherapy Treatment Techniques Amid Growing Demand for Precision Cancer Care

/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company has opened the doors of its new global training facility, the Accuray...

Accuray to Host Investor Day at ASTRO on October 3, 2023

/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company will host a discussion with analysts and investors on Tuesday, October 3,...

Commit To Purchase Accuray At $2, Earn 9% Annualized Using Options

Accuray Receives FDA Clearance for VitalHold™ on the Radixact® System; Breast Cancer Treatment Option Will Also Be Available in the EU Market

/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company has received 510(k) clearance from the U.S. Food and Drug Administration...

Accuray GAAP EPS of -$0.03 misses by $0.04, revenue of $118.3M misses by $3.44M (NASDAQ:ARAY)

Accuray press release (ARAY): Q4 GAAP EPS of -$0.03 misses by $0.04.Revenue of $118.3M (+7.5% Y/Y) misses by $3.44M.The Company is introducing guidance for fiscal year 2024...

Accuray Reports Fourth Quarter and Fiscal 2023 Financial Results

/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal 2023, ended June 30, 2023. Fourth...

Noteworthy Monday Option Activity: TSLA, SOVO, ARAY

Accuray to Report Fiscal Year-End 2023 Financial Results on August 9, 2023

/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the fourth quarter and fiscal year 2023, ended June 30, 2023, during a...

Accuray Incorporated Announces Its Addition to the Russell 2000® Index

/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that as part of the annual reconstitution of the Russell stock indexes, the Company will be...

Cognizant Accuray for betterment of its radiation therapy business (NASDAQ:CTSH)

Cognizant (CTSH) partners with Accuray (ARAY) for SAP S/4HANA development support and obtain better data and analytics, and achieve greater business efficiencies. Cognizant...

Cognizant is Partnering with Accuray to Accelerate Corporate Transformation and Drive Operational Efficiency in Their Radiation Therapy Business

/PRNewswire/ -- Cognizant (NASDAQ: CTSH) today announced that it is partnering with Accuray Incorporated (NASDAQ: ARAY) to support the company's deployment of...

Accuray Announces Suzanne Winter Selected as One of the Top 50 Healthcare Technology CEOs of 2023

/PRNewswire/ -- The global Accuray Incorporated (NASDAQ: ARAY) team is proud to announce that president and CEO Suzanne Winter has been recognized by The...